MSMichal R. Szymanski

Michal R. Szymanski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michal R. Szymanski has a total of 111 co-authors. Here are the top co-authors by number of shared publications:

  • Maria J. Jezewska

    Department of Biochemistry and Molecular Biology and ‡Department of Obstetrics and Gynecology, The Sealy Center for Structural Biology, Sealy Center for Cancer Cell Biology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, Texas 77555-1053, United States

    16 shared publications
  • Wlodzimierz Bujalowski

    Department of Obstetrics and Gynecology, The Sealy Center for Structural Biology, Sealy Center for Cancer Cell Biology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, Texas 77555-1053

    13 shared publications
  • Y. Whitney Yin

    Department of Biochemistry and Molecular Biology, University of Texas Medical Branch , Galveston, TX 77555

    6 shared publications
  • Anasuya Roychowdhury

    Biochemistry and Cell Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Odisha, 752050, India

    4 shared publications
  • Andrzej Dubiel

    Intercollegiate Faculty of Biotechnology of the University of Gdansk and Medical University of Gdansk, Gdansk, Poland

    3 shared publications
  • Anna Karlowicz

    Intercollegiate Faculty of Biotechnology of the University of Gdansk and Medical University of Gdansk, Gdansk, Poland

    3 shared publications

Latest Publications

  • Open Access

    Mitochondrial exonuclease EXOG supports DNA integrity by the removal of single-stranded DNA flaps

    by Anna Karlowicz, Andrzej B Dubiel, Marta Wyszkowska, Kazi Amirul Hossain, Jacek Czub, Michal R Szymanski

    Single-stranded DNA (ssDNA) is an important intermediate generated during various cellular DNA transactions, primarily during long-patch base excision repair. When displaced by DNA polymerase during strand displacement DNA synthesis, ssDNA forms 5′ overhangs (flaps) that are either cleaved by DNA nucleases or protected from degradation upon binding of single-stranded DNA-binding proteins (SSB). Several nucleases are involved in the removal of ssDNA flaps in human mitochondria, namely the endonucleases FEN1 and DNA2, as well as the exonuclease MGME1. In this study, we show that another mitochondrial nuclease, EXOG, cleaves DNA flaps in both free and SSB-protected forms. We established that the presence of the Wing domain in EXOG structure provides additional binding site for ssDNA and 5′ flaps irrespective of monovalent salt concentration. Importantly, DNA flap cleavage by EXOG is compatible with the activity of other mitochondrial enzymes involved in DNA replication/repair, e.g. mtSSB, Pol γ, and Lig III, as we were able to reconstitute a multistep reaction of DNA synthesis, flap removal, and nick ligation. Our findings highlight the versatile role of EXOG in maintaining mitochondrial DNA integrity, expanding its DNA processing repertoire to include ssDNA flap removal.


  • Open Access

    Biochemical evidence for conformational variants in the anti-viral and pro-metastatic protein IFITM1

    by Marta Nekulová, Marta Wyszkowska, Nela Friedlová, Lukáš Uhrík, Filip Zavadil Kokáš, Václav Hrabal, Lenka Hernychová, Bořivoj Vojtěšek, Ted R. Hupp, Michał R. Szymański

    Interferon induced transmembrane proteins (IFITMs) play a dual role in the restriction of RNA viruses and in cancer progression, yet the mechanism of their action remains unknown. Currently, there is no data about the basic biochemical features or biophysical properties of the IFITM1 protein. In this work, we report on description and biochemical characterization of three conformational variants/oligomeric species of recombinant IFITM1 protein derived from an Escherichia coli expression system. The protein was extracted from the membrane fraction, affinity purified, and separated by size exclusion chromatography where two distinct oligomeric species were observed in addition to the expected monomer. These species remained stable upon re-chromatography and were designated as “dimer” and “oligomer” according to their estimated molecular weight. The dimer was found to be less stable compared to the oligomer using circular dichroism thermal denaturation and incubation with a reducing agent. A two-site ELISA and HDX mass spectrometry suggested the existence of structural motif within the N-terminal part of IFITM1 which might be significant in oligomer formation. Together, these data show the unusual propensity of recombinant IFITM1 to naturally assemble into very stable oligomeric species whose study might shed light on IFITM1 anti-viral and pro-oncogenic functions in cells.


  • Human EXOG Possesses Strong AP Hydrolysis Activity: Implication on Mitochondrial DNA Base Excision Repair

    by Michal R. Szymanski, Anna Karlowicz, Geoffrey K. Herrmann, Yana Cen, Y. Whitney Yin

    Most oxidative damage on mitochondrial DNA is corrected by the base excision repair (BER) pathway. However, the enzyme that catalyzes the rate-limiting reaction-deoxyribose phosphate (dRP) removal-in the multienzymatic reaction pathway has not been completely determined in mitochondria. Also unclear is how a logical order of enzymatic reactions is ensured. Here, we present structural and enzymatic studies showing that human mitochondrial EXOG (hEXOG) exhibits strong 5 '-dRP removal ability. We show that, unlike the canonical dRP lyases that act on a single substrate, hEXOG functions on a variety of abasic sites, including 5 '-dRP, its oxidized product deoxyribonolactone (dL), and the stable synthetic analogue tetrahy-drofuran (THF). We determined crystal structures of hEXOG complexed with a THF-containing DNA and with a partial gapped DNA to 2.9 and 2.1 angstrom resolutions, respectively. The structures illustrate that hEXOG uses a controlled 5 '-exonuclease activity to cleave the third phosphodiester bond away from the 5 '-abasic site. This study provides a structural basis for hEXOG's broad spectrum of substrates. Further, we show that hEXOG can set the order of BER reactions by generating an ideal substrate for the subsequent reaction in BER and inhibit off-pathway reactions.


  • Open Access

    In vitro reconstitution reveals a key role of human mitochondrial EXOG in RNA primer processing

    by Anna Karlowicz, Andrzej B Dubiel, Jolanta Czerwinska, Adela Bledea, Piotr Purzycki, Marta Grzelewska, Ryan J McAuley, Roman J Szczesny, Gabriela Brzuska, Ewelina Krol, et al.

    The removal of RNA primers is essential for mitochondrial DNA (mtDNA) replication. Several nucleases have been implicated in RNA primer removal in human mitochondria, however, no conclusive mechanism has been elucidated. Here, we reconstituted minimal in vitro system capable of processing RNA primers into ligatable DNA ends. We show that human 5′-3′ exonuclease, EXOG, plays a fundamental role in removal of the RNA primer. EXOG cleaves short and long RNA-containing flaps but also in cooperation with RNase H1, processes non-flap RNA-containing intermediates. Our data indicate that the enzymatic activity of both enzymes is necessary to process non-flap RNA-containing intermediates and that regardless of the pathway, EXOG-mediated RNA cleavage is necessary prior to ligation by DNA Ligase III. We also show that upregulation of EXOG levels in mitochondria increases ligation efficiency of RNA-containing substrates and discover physical interactions, both in vitro and in cellulo, between RNase H1 and EXOG, Pol γA, Pol γB and Lig III but not FEN1, which we demonstrate to be absent from mitochondria of human lung epithelial cells. Together, using human mtDNA replication enzymes, we reconstitute for the first time RNA primer removal reaction and propose a novel model for RNA primer processing in human mitochondria.


  • Interferon-dependant and immune cell-based mechanisms of antiviral resistance of the human lung vascular endothelium infected with rhinovirus HRV16

    by Mateusz Gawrysiak, Adrian Gajewski, Robert Szewczyk, Mateusz Kobierecki, Michał Szymański, Izabela Gulbas, Aleksandra Likońska, Sylwia Michlewska, Marek L. Kowalski, Maciej Chałubiński

    Introduction: HRV16 may infect human lung vascular endothelium. However, the relevance of anti-viral immune responses orchestrated by virus-infected endothelial cells in asthma exacerbations is unknown. Aim: To assess the effect of HRV16 on interferon-dependant and immune cell-based mechanisms of antiviral resistance of the human lung microvascular endothelium (HMVEC-L). Methods: HMVEC-L were incubated with HRV-16. Virus copy number, interferons, cytokines, IRFs and PRRs mRNA expression was assessed by real time PCR, protein levels by BioPlex. OAS-1 and PKR expression were assessed in real time PCR, flow cytometry and confocal microscope. Migration was assessed in RTCA-DP. Anti-ICAM-1 Abs were used to block virus entry receptor Results: In HMVEC-L, viral copy number peaked at 5h upon incubation with HRV16, and was associated with up-regulation of viral RNA sensors (i.e. RIG-I); then subsequently decreased. The decrease of viral load was accompanied by up-regulation of OAS-1 and PKR. Enhanced cell migratory properties and self-restoration of endothelium were noted. HRV16 induced the release of cytokines responsible for the antiviral mechanisms (INF-γ), NK cell recruitment (RANTES, IP-10, MIP-1β) and Tc cell activation (IL-2, IL-9, IL-7, MCP-1). Anti-ICAM-1 Abs reduced viral biological effects Conclusions: HRV16 may activate intracellular interferon-dependent and immune cell-based mechanisms of antiviral resistance in HMVEC-L, which suggests the lung endothelium as an orchestrator of antiviral immune response in rhinoviral asthma exacerbations. NCN 2017/25/B/NZ5/01575; Student Grants of the Medical University of Lodz 564/1-000-00/564-20-041

  • Open Access

    Biochemical and Biophysical Characterization of the dsDNA Packaging Motor from the Lactococcus lactis Bacteriophage Asccphi28

    by Emilio Reyes-Aldrete, Erik A. Dill, Cecile Bussetta, Michal R. Szymanski, Geoffrey Diemer, Priyank Maindola, Mark A. White, Wlodzimierz M. Bujalowski, Kyung H. Choi, Marc C. Morais

    Double-stranded DNA viruses package their genomes into pre-assembled protein procapsids. This process is driven by macromolecular motors that transiently assemble at a unique vertex of the procapsid and utilize homomeric ring ATPases to couple genome encapsidation to ATP hydrolysis. Here, we describe the biochemical and biophysical characterization of the packaging ATPase from Lactococcus lactis phage asccφ28. Size-exclusion chromatography (SEC), analytical ultracentrifugation (AUC), small angle X-ray scattering (SAXS), and negative stain transmission electron microscopy (TEM) indicate that the ~45 kDa protein formed a 443 kDa cylindrical assembly with a maximum dimension of ~155 Å and radius of gyration of ~54 Å. Together with the dimensions of the crystallographic asymmetric unit from preliminary X-ray diffraction experiments, these results indicate that gp11 forms a decameric D5-symmetric complex consisting of two pentameric rings related by 2-fold symmetry. Additional kinetic analysis shows that recombinantly expressed gp11 has ATPase activity comparable to that of functional ATPase rings assembled on procapsids in other genome packaging systems. Hence, gp11 forms rings in solution that likely reflect the fully assembled ATPases in active virus-bound motor complexes. Whereas ATPase functionality in other double-stranded DNA (dsDNA) phage packaging systems requires assembly on viral capsids, the ability to form functional rings in solution imparts gp11 with significant advantages for high-resolution structural studies and rigorous biophysical/biochemical analysis.


  • Whole exome sequencing identifies a homozygous POLG2 missense variant in an adult patient presenting with optic atrophy, movement disorders, premature ovarian failure and mitochondrial DNA depletion

    by Petra Dosekova, Andrzej Dubiel, Anna Karlowicz, Szymon Zietkiewicz, Malgorzata Rydzanicz, Viera Habalova, Victor Murcia Pienkowski, Miriam Skirkova, Vladimir Han, Alexandra Mosejova, et al.


  • Transcription polymerase–catalyzed emergence of novel RNA replicons

    by Nimit Jain, Lucas R. Blauch, Michal R. Szymanski, Rhiju Das, Sindy K. Y. Tang, Y. Whitney Yin, Andrew Z. Fire

    Revisiting replicating RNAs: DNA-dependent RNA polymerases are well known for their ability to produce RNA from DNA templates. Much less is known about their noncanonical activity: the generation and replication of RNA from RNA templates. Deeper insights into this process could shed light on questions relating to the origin of life, molecular evolution, and the replication of certain RNA pathogens such as hepatitis delta virus and plant viroids. Jain et al. explore in detail how the bacteriophage T7 RNA polymerase generates and amplifies diverse RNA sequences in vitro. Using sequencing, microfluidics, and bioinformatics, they chart the emergence and evolution of replicating RNA motifs and identify mechanisms that explain their selection and structures. Science , this issue p. eaay0688


  • Open Access

    A domain in human EXOG converts apoptotic endonuclease to DNA-repair exonuclease

    by Michal R. Szymanski, Wangsheng Yu, Aleksandra M. Gmyrek, Mark A. White, Ian J. Molineux, J. Ching Lee, Y. Whitney Yin

    Human EXOG (hEXOG) is a 5′-exonuclease that is crucial for mitochondrial DNA repair; the enzyme belongs to a nonspecific nuclease family that includes the apoptotic endonuclease EndoG. Here we report biochemical and structural studies of hEXOG, including structures in its apo form and in a complex with DNA at 1.81 and 1.85 Å resolution, respectively. A Wing domain, absent in other ββα-Me members, suppresses endonuclease activity, but confers on hEXOG a strong 5′-dsDNA exonuclease activity that precisely excises a dinucleotide using an intrinsic ‘tape-measure’. The symmetrical apo hEXOG homodimer becomes asymmetrical upon binding to DNA, providing a structural basis for how substrate DNA bound to one active site allosterically regulates the activity of the other. These properties of hEXOG suggest a pathway for mitochondrial BER that provides an optimal substrate for subsequent gap-filling synthesis by DNA polymerase γ.


  • The DNA Polymerase Gamma R953C Mutant Is Associated with Antiretroviral Therapy-Induced Mitochondrial Toxicity

    by Min Li, Andrea C. Mislak, Yram Foli, Esinam Agbosu, Vivek Bose, Shreya Bhandari, Michal R. Szymanski, Christie K. Shumate, Y. Whitney Yin, Karen S. Anderson, et al.

    We found a heterozygous C2857T mutation (R953C) in polymerase gamma (Pol-γ) in an HIV-infected patient with mitochondrial toxicity. The R953C Pol-γ mutant binding affinity for dCTP is 8-fold less than that of the wild type. The R953C mutant shows a 4-fold decrease in discrimination of analog nucleotides relative to the wild type. R953 is located on the “O-helix” that forms the substrate deoxynucleoside triphosphate (dNTP) binding site; the interactions of R953 with E1056 and Y986 may stabilize the O-helix and affect polymerase activity.